Impact of SGLT2 inhibition on markers of reverse cardiac remodelling in heart failure: Systematic review and meta-analysis.

ESC Heart Fail · 2024 · PMC11631341 · PMID 39056515

Europe PMC DOI

hedged sentence

0.1800

closest p · 3.6× alpha

0.1800

boldest claim

The sentences

did not reach statistical significanceP = 0.18not close (p > 0.1)

A trend towards improved LV GLS with SGLT2 inhibition versus controls was noted; however, this did not reach statistical significance (mean increase +0.42% [95% CI ‐0.19 to 1.02; z = 1.35; P = 0.18).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.